ARCHIVES

Large Phase III Trial Seeks Optimal Use Of Tykerb vs. Herceptin In Breast Cancer

This article is from The Cancer Letter archive.

Vol. 31 No. 2 | February 29, 2008

Download PDF Visit The Full Archive

Related Articles

Organ Systems Support Contract To Cost More than OSCC Grant

September 30, 1988

DCT Board Approves $17 Million In Recompetition; Asks Some Be Switched To Cooperative Agreements

November 23, 1979

NCCS Selects New President

October 9, 2009

Galeterone Shows Potential In CRPC AR Variants, Study Says

November 28, 2014

Reviewers Duck Problem Of Naming Four More Comprehensive Centers, Leave It Up To Rauscher To Pick From List Of 11

March 29, 1974

Budget Year

November 12, 2010